DIA Asia 2021-The Evolution Of Clinical Trials And Regulatory Science In A Post-Pandemic Digital World In Asia

The timing is as per Singapore Time Zone

Back to Agenda

Panel discussion: Digital Transformation in Regulatory Affairs

Executive Director, International Labeling Group, Global Regulatory Affairs, Pfizer Inc, United Kingdom

Director of Office of Informatics and Management for Safety, Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Senior Director, Strategy and Innovation, Global Regulatory Policy, Janssen, Spain

Executive Vice President , LinkDoc Technology (Beijing) Co. Ltd, China

Have an account?